Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sneha Pandithar
Institutions:
Fred and Pamela Buffett Cancer Center,
University of Nebraska Medical Center
Observed institutions:
Albany College of Pharmacy and Health Sciences,
Fred and Pamela Buffett Cancer Center,
University of Nebraska Medical Center
ORCID:
0009-0007-1868-8279
Observed ORCID:
0009-0007-1868-8279
OpenAlex ID:
A5029939934
The role of CXCL1 in crosstalk between endocrine resistant breast cancer and fibroblast
2024
·
Sneha Pandithar
, Daniel Galke
, et al.
·
Molecular Biology Reports
·
6
PDF
Surveying the Proteome-Wide Landscape of Mitoxantrone and Examining Drug Sensitivity in BRCA1-Deficient Ovarian Cancer Using Quantitative Proteomics
2025
·
Savanna Wallin
, Sneha Pandithar
, et al.
·
Proteomes
PDF
Abstract 650: Reparixin, CXCR1/2 inhibitor in combination with CDK4/6 inhibitors attenuates endocrine resistant breast cancer growth and metastasis
2022
·
Sneha Pandithar
, Olivia Reff
, et al.
·
Cancer Research
Show more works
View as search
Works count:
3
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type